课题基金 / 基金详情

Free Radicals and Mitochondria in Neuronal Apoptosis

Free Radicals and Mitochondria in Neuronal Apoptosis
神经元凋亡中的自由基和线粒体
批准号:
7002170
负责人:
JAMES Lee FRANKLIN
金额:
$26.59万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1998
资助国家:
美国
项目状态:
已结题
起止时间:
1998-12-01 至 2007-12-31

项目摘要

项目成果

JAMES Lee FRANKLIN的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Half of all neurons produced during embryogenesis undergo apoptotic death shortly before birth or soon thereafter. Neuronal death with characteristics similar to those seen during development also occurs after stroke and in neurodegenerative diseases such as Alzheimer's disease. Similarities between developmental death and death caused by insult or disease suggests comparable processes kill neurons in both situations and that information gained about mechanisms of developmental death may aid in understanding and treating pathological death. We use two cell culture models to investigate mechanisms of apoptosis during neuronal development: 1) sympathetic neurons deprived of nerve growth factor and, 2) cerebellar granule neurons deprived of serum in low potassium medium. Data generated during the initial funding period of this grant shows that there is a dramatic increase in mitochondrial-derived reactive oxygen species (ROS) during the apoptotic death of both of these cell types. These ROS lie downstream of the pro-apoptotic protein, Bax, which induces apoptosis by causing release of apoptogenic factors from the mitochondria into the cytoplasm. Our evidence suggests that the ROS are critical for this release. The goal of this research proposal is to understand the role of these ROS in neuronal apoptosis. The first four specific aims will be done in sympathetic neurons. Specific aim 1 will test the hypotheses that Bax induces elevated ROS by increasing production of superoxide by mitochondria. The goal of specific aim 2 is to test the hypothesis that caspase proteases increase ROS by attacking mitochondrial respiratory complexes. Specific aim 3 will test the hypothesis that the Bax-induced ROS lie downstream from the MLK/JNK kinase pathway. Experiments in specific aim 4 will test the hypothesis that the ROS cause release of apoptogenic factors from mitochondria by opening the outer mitochondrial membrane channel, VDAC. Specific aim 5 will test the generality of the first four specific aims in the cerebellar granule system. We shall use genetic, biochemical, and confocal microscopic techniques to investigate these hypotheses. These studies will provide clear answers about the mechanism by which Bax causes increased ROS during neuronal apoptosis and how these ROS contribute to cell death. They will further our long-term goals of understanding mechanisms of apoptosis and of identifying ways of manipulating this death.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Bax, Caspases, and Oxidative Stress in the Aging Brain
  • 批准号:
    8953564
  • 项目类别:
  • 资助金额:
    $7.5万
  • 财政年份:
    2015
  • 负责人:
    JAMES Lee FRANKLIN
  • 依托单位:
Bax, Caspases, and Oxidative Stress in the Aging Brain
  • 批准号:
    9127052
  • 项目类别:
  • 资助金额:
    $7.5万
  • 财政年份:
    2015
  • 负责人:
    JAMES Lee FRANKLIN
  • 依托单位:
FREE RADICALS AND MITOCHONDRIA IN NEURONAL APOPTOSIS
  • 批准号:
    6126363
  • 项目类别:
  • 资助金额:
    $9.73万
  • 财政年份:
    1998
  • 负责人:
    JAMES Lee FRANKLIN
  • 依托单位:
FREE RADICALS AND MITOCHONDRIA IN NEURONAL APOPTOSIS
  • 批准号:
    2750973
  • 项目类别:
  • 资助金额:
    $9.36万
  • 财政年份:
    1998
  • 负责人:
    JAMES Lee FRANKLIN
  • 依托单位:
国内基金
海外基金
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
  • 批准号:
    LBY21H010001
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2020
  • 负责人:
    郑绪阳
  • 依托单位:
去乙酰化酶SIRT1在前体mRNA可变剪切中的作用及其生理病理效应研究
  • 批准号:
    31970691
  • 项目类别:
    面上项目
  • 资助金额:
    58.0万元
  • 批准年份:
    2019
  • 负责人:
    张胜萍
  • 依托单位:
TM9SF4调控非小细胞肺癌细胞凋亡机制研究
  • 批准号:
    31900527
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    24.0万元
  • 批准年份:
    2019
  • 负责人:
    孙磊
  • 依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
  • 批准号:
    81703335
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    20.0万元
  • 批准年份:
    2017
  • 负责人:
    卫高菲
  • 依托单位: